GSK's Albiglutide On Course To Indian Debut?
This article was originally published in Scrip
Executive Summary
GlaxoSmithKline appears to be on course to bringing its once-weekly diabetes therapy albiglutide (Tanzeum/ Eperzan) to India, after a key local expert panel recommended the product for marketing.